IL6 and chronic kidney disease: Studies have shown elevated levels of inflammatorymarkers in the plasma of CKD patients, while the levels of tumor necrosis factor-α (TNF-α), Interleukin-6 (IL-6)[17, 18] and other pro-inflammatory markers are also increased in CKD-G5Dpatients.